13F

Stock

Acrivon Therapeutics, Inc.

ACRV · held by 2 managers

Reported value

$185.3K

Holders

2

+1 new · −0 exited

Holders’ est. mark

−$65.4K

Price effect on 1 books still in the name

Largest holder

$120.5K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC24.5K$120.5K−$65.4KCut−$14.3K
Marex Group plc13.2K$64.9KNew

Positions as of Q4 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.